NEWS & RESOURCES
Alpheus Medical Announces Formation of World-Class Scientific Advisory Board
SAB to provide meaningful guidance as company begins first-in-human (FIH) clinical trial of their proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas.
Alpheus Medical closes $16m in Series A financing for novel glioma brain cancer treatment
Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today announced it has closed $16M in Series A financing.
© 2021 Alpheus Medical Inc., All Rights Reserved. | CAUTION: Investigational device in the United States. Limited by Federal law to investigational use.